IFNK |
---|
|
Identifiers |
---|
Aliases |
IFNK, IFNT1, INFE1, interferon kappa |
---|
External IDs |
MGI: 2683287 HomoloGene: 36384 GeneCards: IFNK |
---|
Gene location (Human) |
---|
| Chr. |
Chromosome 9 (human)[1] |
---|
| Band |
9p21.2 |
Start |
27,524,314 bp[1] |
---|
End |
27,526,498 bp[1] |
---|
|
Gene location (Mouse) |
---|
| Chr. |
Chromosome 4 (mouse)[2] |
---|
| Band |
4|4 A5 |
Start |
35,152,056 bp[2] |
---|
End |
35,154,005 bp[2] |
---|
|
Gene ontology |
---|
Molecular function |
• cytokine activity • type I interferon receptor binding • cytokine receptor binding
|
---|
Cellular component |
• extracellular region • extracellular space
|
---|
Biological process |
• natural killer cell activation involved in immune response • B cell differentiation • defense response • response to virus • natural killer cell activation • B cell proliferation • regulation of transcription, DNA-templated • humoral immune response • adaptive immune response • positive regulation of peptidyl-serine phosphorylation of STAT protein • defense response to virus • response to exogenous dsRNA • negative regulation of cell proliferation • cytokine-mediated signaling pathway • positive regulation of innate immune response • T cell activation involved in immune response • regulation of receptor activity
|
---|
Sources:Amigo / QuickGO
|
|
Orthologs |
---|
Species |
Human |
Mouse |
---|
Entrez |
|
|
---|
Ensembl |
|
|
---|
UniProt |
|
|
---|
RefSeq (mRNA) |
|
|
---|
RefSeq (protein) |
|
|
---|
Location (UCSC) |
Chr 9: 27.52 – 27.53 Mb |
Chr 4: 35.15 – 35.15 Mb |
---|
PubMed search |
[3] |
[4] |
---|
Wikidata |
View/Edit Human |
View/Edit Mouse |
|
Interferon kappa, also known as IFN-kappa, is a protein that in humans is encoded by the IFNK gene.[5][6][7]
Function[edit]
IFN-kappa is a member of the type I interferon family. Type I interferons are a group of related glycoproteins that play an important role in host defenses against viral infections. This protein is expressed in keratinocytes and the gene is found on chromosome 9, adjacent to the type I interferon cluster.[5]
References[edit]
^ abc GRCh38: Ensembl release 89: ENSG00000147896 - Ensembl, May 2017
^ abc GRCm38: Ensembl release 89: ENSMUSG00000042993 - Ensembl, May 2017
^ "Human PubMed Reference:"..mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em
^ "Mouse PubMed Reference:".
^ ab "Entrez Gene: interferon".
^ LaFleur DW, Nardelli B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, Chen G, Ruben SM, Pitha PM, Coleman TA, Moore PA (October 2001). "Interferon-kappa, a novel type I interferon expressed in human keratinocytes". J. Biol. Chem. 276 (43): 39765–71. doi:10.1074/jbc.M102502200. PMID 11514542.
^ Nardelli B, Zaritskaya L, Semenuk M, Cho YH, LaFleur DW, Shah D, Ullrich S, Girolomoni G, Albanesi C, Moore PA (November 2002). "Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system". J. Immunol. 169 (9): 4822–30. doi:10.4049/jimmunol.169.9.4822. PMID 12391192.
3.Antiviral activity of transiently expressed IFN-kappa is cell-associated. Buontempo, P.J., Jubin, R.G., Buontempo, C.A., Wagner, N.E., Reyes, G.R., Baroudy, B.M. J. Interferon Cytokine Res. (2006) [Pubmed]
Further reading[edit]
.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%
Liu C, Batliwalla F, Li W, et al. (2008). "Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis". Mol. Med. 14 (9–10): 575–81. doi:10.2119/2008-00056.Liu. PMC 2443997. PMID 18615156.
DeCarlo CA, Severini A, Edler L, et al. (2010). "IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes". Lab. Invest. 90 (10): 1482–91. doi:10.1038/labinvest.2010.95. PMID 20479716.
Silva LK, Blanton RE, Parrado AR, et al. (2010). "Dengue hemorrhagic fever is associated with polymorphisms in JAK1". Eur. J. Hum. Genet. 18 (11): 1221–7. doi:10.1038/ejhg.2010.98. PMC 2950898. PMID 20588308.
Yang XR, Liang X, Pfeiffer RM, et al. (2010). "Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations". Fam. Cancer. 9 (4): 625–33. doi:10.1007/s10689-010-9356-3. PMC 3233727. PMID 20574843.
Ferreira RC, Pan-Hammarström Q, Graham RR, et al. (2010). "Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency". Nat. Genet. 42 (9): 777–80. doi:10.1038/ng.644. PMID 20694011.
Laaksovirta H, Peuralinna T, Schymick JC, et al. (2010). "Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study". Lancet Neurol. 9 (10): 978–85. doi:10.1016/S1474-4422(10)70184-8. PMC 2965392. PMID 20801718.
Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
Rincon-Orozco B, Halec G, Rosenberger S, et al. (2009). "Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells". Cancer Res. 69 (22): 8718–25. doi:10.1158/0008-5472.CAN-09-0550. PMID 19887612.
Humphray SJ, Oliver K, Hunt AR, et al. (2004). "DNA sequence and analysis of human chromosome 9". Nature. 429 (6990): 369–74. doi:10.1038/nature02465. PMC 2734081. PMID 15164053.
Zhang Z, Henzel WJ (2004). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
van Es MA, Veldink JH, Saris CG, et al. (2009). "Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis". Nat. Genet. 41 (10): 1083–7. doi:10.1038/ng.442. PMID 19734901.
Harley IT, Niewold TB, Stormont RM, et al. (2010). "The role of genetic variation near interferon-kappa in systemic lupus erythematosus". J. Biomed. Biotechnol. 2010: 1. doi:10.1155/2010/706825. PMC 2914299. PMID 20706608.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Cell signaling: cytokines
|
---|
By family |
Chemokine |
CCL |
- CCL1
CCL2/MCP1
CCL3/MIP1α
CCL4/MIP1β
CCL5/RANTES
- CCL6
- CCL7
- CCL8
- CCL9
- CCL11
- CCL12
- CCL13
- CCL14
- CCL15
- CCL16
- CCL17
CCL18/PARC/DCCK1/AMAC1/MIP4
- CCL19
- CCL20
- CCL21
- CCL22
- CCL23
- CCL24
- CCL25
- CCL26
- CCL27
- CCL28
|
---|
CXCL |
CXCL1/KC
- CXCL2
- CXCL3
- CXCL4
- CXCL5
- CXCL6
- CXCL7
- CXCL8/IL8
- CXCL9
- CXCL10
- CXCL11
- CXCL12
- CXCL13
- CXCL14
- CXCL15
- CXCL16
- CXCL17
|
---|
CX3CL |
|
---|
XCL |
|
---|
|
---|
TNF |
- TNFA
Lymphotoxin
- TNFSF4
- TNFSF5/CD40LG
- TNFSF6
- TNFSF7
- TNFSF8
- TNFSF9
- TNFSF10
- TNFSF11
- TNFSF13
- TNFSF13B
- EDA
|
---|
Interleukin |
Type I (grouped by receptor subunit) |
γ chain |
IL2/IL15
IL4/IL13
- IL7
- IL9
- IL21
|
---|
β chain |
|
---|
IL6 like/gp130
|
|
---|
IL12 family/IL12RB1
|
|
---|
Other |
|
---|
|
---|
Type II |
IL10 family |
IL10/IL22
- IL19
- IL20
- IL24
- IL26
Interferon type III
|
---|
Interferon |
I |
- IFNA1
- IFNA2
- IFNA4
- IFNA5
- IFNA6
- IFNA7
- IFNA8
- IFNA10
- IFNA13
- IFNA14
- IFNA16
- IFNA17
- IFNA21
- IFNB1
- IFNK
- IFNW1
|
---|
II |
|
---|
|
---|
|
---|
Ig superfamily |
IL1 family: IL1A/IL1F1
- IL1B/IL1F2
- 1Ra/IL1F3
- IL1F5
- IL1F6
- IL1F7
- IL1F8
- IL1F9
- IL1F10
- 33/IL1F11
- 18/IL1G
|
---|
IL17 family |
|
---|
|
---|
Other |
Hematopoietic
- KITLG
- Colony-stimulating factor
- SPP1
- MIF
|
---|
|
---|
By function/ cell |
|
---|
Cytokine receptor modulators
|
---|
Chemokine |
|
---|
CSF |
Erythropoietin |
Agonists: ARA-290
- Asialo erythropoietin
- Carbamylated erythropoietin
- CNTO-530
- Darbepoetin alfa
- Epoetin alfa
- Epoetin beta
- Epoetin delta
- Epoetin epsilon
- Epoetin gamma
- Epoetin kappa
- Epoetin omega
- Epoetin theta
- Epoetin zeta
- Erythropoietin (EPO)
- Erythropoietin-Fc
- Methoxy polyethylene glycol-epoetin beta (CERA/Mircera)
- Peginesatide
- Pegol sihematide (EPO-018B)
|
---|
G-CSF (CSF3) |
Agonists: Filgrastim
- Granulocyte colony-stimulating factor
- Lenograstim
- Leridistim
- Lipegfilgrastim
- Nartograstim
- Pegfilgrastim
- Pegnartograstim
|
---|
GM-CSF (CSF2) |
Agonists: Ecogramostim
- Granulocyte macrophage colony-stimulating factor
- Milodistim
- Molgramostim
- Regramostim
- Sargramostim
Antibodies: Mavrilimumab
- MOR103
- Namilumab
|
---|
M-CSF (CSF1) |
Agonists: Cilmostim
- Interleukin-34
- Lanimostim
- Macrophage colony-stimulating factor
- Mirimostim
Kinase inhibitors: Agerafenib
|
---|
SCF (c-Kit) |
|
---|
Thrombopoietin |
Agonists: Eltrombopag
- Pegacaristim
- Promegapoietin
- Romiplostim
- Thrombopoietin (THPO, MGDF)
|
---|
|
---|
Interferon |
IFNAR (α/β, I) |
Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
Antibodies: Anifrolumab
- Faralimomab
- MEDI-545
- Rontalizumab
- Sifalimumab
Decoy receptors: Bifarcept
|
---|
IFNGR (γ, II) |
Agonists: Interferon gamma (IFN-γ)
- Interferon gamma 1b
Antibodies: Emapalumab
- Fontolizumab
|
---|
IFNLR (λ, III) |
- See IL-28R (IFNLR) here instead.
|
---|
|
---|
Interleukin |
|
---|
TGFβ |
|
---|
TNF |
|
---|
Others |
JAK (inhibitors)
|
JAK1 |
- Baricitinib
- Filgotinib
- Momelotinib
- Oclacitinib
- Ruxolitinib
- Tofacitinib (tasocitinib, CP-690550)
- Upadacitinib
|
---|
JAK2 |
- AG-490
- Atiprimod
- AZD-1480
- Baricitinib
- CHZ868
- Cucurbitacin I (elatericin B, JSI-124)
- CYT387
- Lestaurtinib
- NSC-7908
- NSC-33994
- Pacritinib
- Ruxolitinib
- SD-1008
- Tofacitinib (tasocitinib, CP-690550)
|
---|
JAK3 |
- AG-490
- Cercosporamide
- TCS-21311
- Tofacitinib (tasocitinib, CP-690550)
- WHI-P 154
- ZM-39923
- ZM-449829
|
---|
|
---|
Others |
Additional cytokines: Cardiotrophin 1 (CT-1)
- FMS-like tyrosine kinase 3 ligand (FLT3L)
- Leukemia/leukocyte inhibitory factor (LIF)
- Oncostatin M (OSM)
- Thymic stromal lymphopoietin (TSLP)
Additional cytokine receptor modulators: Emfilermin
- Lestaurtinib
- Midostaurin
- Quizartinib
- Sorafenib
- Sunitinib
|
---|
|
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Growth factor receptor modulators
|